Dr. Ene-Obong holds a PhD in Cancer Biology from University of London, a Master’s degree in human molecular genetics from Imperial College London and a Master’s degree in Business Management from Claremont Colleges, California.
He is the founder and Chief Executive Officer of 54gene, a genomics research, services, and development company established to significantly improve the inclusion of African populations in clinical global genomics research. Prior to 54gene, Dr. Ene-Obong worked with leading healthcare organisations, including Fortune 100 pharmaceutical companies, academic and research institutions, and governments as a management consultant with PwC. He also worked as a cancer researcher. He has extensive experience operating in the US, UK, .and Nigerian healthcare industries
